HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues].

Abstract
Since there have been relatively high incidence of cancer of the digestive organs in Japan, many 5-fluorouracil analogues have been studied as the drugs to treat such cancers. Beside these fluoropyrimine compounds, cytosine arabinoside (ara-C) analogues have also been studied, and some of them have shown appreciable clinical activities against human malignancies. In this paper, as such analogues, experimental and clinical studies of gemcitabine (dFdC). DMDC and cytarabine ocfosfate were reviewed. Among these drugs, gemcitabine (Eli Lilly, Japan) showed more than 20% response rate against non-small cell lung cancer in the late phase II study in Japan. Unfortunately, clinical study of DMDC (Yoshitomi) is currently suspended because of the lack of the hint of clinical activity, but the author believes that this might show some clinical activities by changing the treatment regimens in the future. Cytarabine ocfosfate (Nippon Kayaku) has already put on market as the first drug to be active against ANLL and MDS by giving orally.
AuthorsS Tsukagoshi
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 24 Issue 7 Pg. 761-70 (May 1997) ISSN: 0385-0684 [Print] Japan
PMID9170512 (Publication Type: Journal Article, Review)
Chemical References
  • Antimetabolites, Antineoplastic
  • Arabinonucleotides
  • Cytarabine
  • Deoxycytidine
  • 1-arabinofuranosylcytosine-5'-stearylphosphate
  • Cytidine Monophosphate
  • 2'-deoxy-2'-methylenecytidine
  • Gemcitabine
Topics
  • Animals
  • Antimetabolites, Antineoplastic (chemistry)
  • Arabinonucleotides (therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Cytarabine (analogs & derivatives)
  • Cytidine Monophosphate (analogs & derivatives, therapeutic use)
  • Deoxycytidine (analogs & derivatives, therapeutic use)
  • Humans
  • Lung Neoplasms (drug therapy)
  • Mice
  • Neoplasm Transplantation
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: